Table 2.
ACR/SLICC+ SLE classified as SLE in the USRDS N=77 |
ACR/SLICC+ SLE classified as non-SLE in the USRDS N=20 |
p value** | |
---|---|---|---|
| |||
Age at ESRD onset, mean (SD), years | 37 (13) | 45 (16) | 0.11 |
| |||
Sex, n(%) men | 10 (13) | - | 0.30 |
| |||
Black race, n(%) | 41 (54) | 15 (79) | 0.048 |
| |||
Hispanic ethnicity, n(%) | 44 (58) | - | 0.01 |
| |||
Hemodialysis as the initial renal replacement modality | 68 (88) | 20 (100) | 0.11 |
| |||
Transplant recipients, n (%) | 40 (52) | - | 0.01 |
| |||
Year of ESRD recorded | |||
<2004 | 24 (31) | - | |
2004–2009 | 40 (52) | - | |
>2009 | 13 (17) | - | 0.11 |
In accordance with the Centers for Medicare and Medicaid Services release of data requirements, cells with fewer than 10 patients per cell were suppressed
p-value for Wilcoxon-Mann-Whitney tests for continuous variables, and Pearson’s Chi-square tests or Fisher’s exact tests for categorical variables